Atreya, R., Irving, P., Fujiya, M., Colombel, J. F., Danese, S., Peyrin-Biroulet, L., Bessissow, T., Panaccione, R., D'Haens, G., van Haaren, S., Neimark, E., Zambrano, J., Zhang, Y., Kligys, K., & Ferrante, M. (n.d.). p548 Efficacy outcomes of placebo maintenance treatment in patients with moderate to severe Crohn's disease who responded to placebo induction therapy: Post-hoc analysis of the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Risankizumab Studies. Journal of Crohn's and colitis, 17, i675–i677. http://access.bl.uk/ark:/81055/vdc_100179844218.0x00002f